Skip to main
6 Followers • 8 Following

Joni

@ucanttopmyramenHealthcare Education
  1. Asset
    Price
  2. PLRX
    Pliant Therapeutics
  3. AC Immune
  4. ACADIA Pharma
  5. ADC Therapeutics
  6. ALX Onconology Holdings Inc
  7. AMC Entertainment
  8. AN2 Therapeutics Inc
  9. ARK Fintech Innovation ETF
  10. ARM Holdings PLC
  11. AST SpaceMobile
  12. AT&T
  13. AXT
  14. AbbVie
  15. Abbott Labs
  16. Above Food Ingredients Inc
  17. Adobe
  18. Agba Acquisition Ltd
  19. Agilysys
  20. Agriforce Growing Systems Ltd
  21. Agrify
  22. Airbnb
  23. Alaska Air Group
  24. Alibaba
  25. Allbirds
  26. Allego NV
  27. Alliance Entertainment Holding Corp
  28. Allied Gaming & Entertainment Inc
  29. Allurion Technologies Holdings Inc
  30. Ally Financial
  31. Alnylam Pharmaceuticals
  32. Alphabet
  33. Alphabet
  34. Amalgamated Financial Corp
  35. Amazon
  36. Ambarella
  37. Ambev
  38. American Rebel Holdings Inc
  39. Ampio Pharmaceuticals Inc
  40. Apple
  41. Asensus Surgical
  42. AstraZeneca
  43. Atai Life Sciences BV
  44. Aurora Cannabis
  45. Axsome Therapeutics
  46. BAIYU Holdings Inc
  47. Babcock & Wilcox Enterprises
  48. Baijiayun Group Ltd
  49. Barnes & Noble Education
  50. Beneficient
  51. Benitec Biopharma Limited Sponsored ADR
  52. Berkshire Hathaway
  53. Better Home & Finance Holding Co
  54. BioNTech SE
  55. BioVie Inc
  56. Birkenstock Holding Plc
  57. Birks Group
  58. Bit Brother Ltd
  59. Bitfarms Ltd
  60. Bitwise Crypto Innovators ETF
  61. Blink Charging
  62. Block
  63. Bloom Energy
  64. Bolt Biotherapeutics
  65. Boston Beer Company
  66. Boston Scientific
  67. Brand Engagement Network Inc
  68. Broadcom
  69. Broadwind Energy
  70. Brooge Energy Limited
  71. C3.ai
  72. C4 Therapeutics
  73. COMPASS Pathways
  74. Caesars Entertainment
  75. Cameco
  76. Canopy Growth
  77. Capital One
  78. Captivision Inc
  79. Carmell Therapeutics Corp
  80. Carnival
  81. Cassava Sciences Inc
  82. Cava Group, Inc.
  83. Celsius Holdings
  84. Centrus Energy
  85. Checkpoint Therapeutics
  86. Cheetah Net Supply Chain Service Inc
  87. Chewy
  88. China Rapid Finance
  89. Cibus Inc
  90. Cidara Therapeutics
  91. Clean Energy Technologies Inc
  92. Clear Secure
  93. ClimateRock
  94. Coca-Cola Bottling
  95. Codexis
  96. Coherus BioSciences
  97. Comcast
  98. Complete Solaria Inc
  99. Compugen
  100. Comtech Telecommunications
  101. Connect Biopharma Holdings
  102. Corcept Therapeutics
  103. Critical Metals Corp
  104. Cronos Group
  105. Cue Biopharma
  106. Cue Health Inc
  107. Cybin
  108. Dave
  109. Dave & Buster's
  110. Denison Mines
  111. Dick's Sporting Goods
  112. Digital Ally Inc
  113. Direct Digital Holdings
  114. Direxion Daily Electric & Autonomous Vehicles Bull 2X Shares
  115. Disney
  116. Dollar Tree
  117. DoorDash
  118. DraftKings
  119. Draganfly Inc
  120. Dyne Therapeutics
  121. EDAP TMS
  122. EOG Resources
  123. ESSA Pharma
  124. Eaton Vance Enhanced Equity Income Fund
  125. Ebix Inc
  126. EchoStar
  127. Edgio Inc
  128. Eli Lilly
  129. Emergent BioSolutions
  130. Encompass Health
  131. Endeavor Group Holdings
  132. Energy Fuels
  133. Engene Holdings Inc
  134. Envoy Medical Inc
  135. Equillium Inc
  136. FibroGen
  137. First Trust India NIFTY 50 Equal Weight ETF
  138. Fiserv Inc
  139. FlexShares STOXX US ESG Impact Index Fund
  140. Forward Industries
  141. Frequency Therapeutics Inc
  142. Freyr Battery Inc
  143. FuboTV
  144. G1 Therapeutics
  145. GH Research PLC
  146. Gain Therapeutics
  147. Gambling.com Group
  148. GameStop
  149. Generation Bio
  150. Global X Artificial Intelligence & Technology ETF
  151. Global X Robotics & Artificial Intelligence ETF
  152. Global X Uranium ETF
  153. Globe Life Inc
  154. Gossamer Bio Inc
  155. Griid Infrastructure Inc
  156. HeartBeam
  157. Helix Energy Solutions Group
  158. Hims & Hers Health
  159. Hologic
  160. Hub Cyber Security Ltd
  161. Immix Biopharma
  162. Imperial Petroleum
  163. Indivior PLC
  164. Intellicheck
  165. Intensity Therapeutics Inc
  166. Intuitive Machines Inc
  167. Intuitive Surgical
  168. Invesco QQQ
  169. Ispire Technology Inc
  170. Janux Therapeutics
  171. Joby Aviation
  172. Just Eat Takeaway.com NV
  173. Kennedy-Wilson Holdings
  174. Keros Therapeutics
  175. Laser Photonics Corp
  176. Legacy Housing Corp
  177. Lemonade
  178. Leonardo DRS Inc
  179. Lexicon Pharmaceuticals
  180. Live Nation
  181. Logistic Properties Of The Americas
  182. Lytus Technologies Holdings PTV Ltd
  183. MGM Resorts
  184. MannKind
  185. Maravai LifeSciences Holdings
  186. Mattel
  187. Matterport
  188. Medtronic
  189. MercadoLibre
  190. Merck
  191. Mesoblast
  192. Meta
  193. Microsoft
  194. Mind Medicine MindMed
  195. Mmtec Inc
  196. Moderna
  197. ModivCare
  198. Modular Medical
  199. Molson Coors Brewing
  200. Momentus
  201. Montana Technologies Corporation
  202. Monte Rosa Therapeutics
  203. Moog
  204. Moolec Science SA
  205. Murano Global BV
  206. NANO Nuclear Energy Inc
  207. NIKE
  208. NVIDIA
  209. Nauticus Robotics Inc
  210. Nektar Therapeutics
  211. NeoVolta Inc
  212. NerdWallet
  213. Netflix
  214. NeueHealth Inc
  215. New Providence Acquisition Corp II
  216. Newegg Commerce
  217. Nifty India Financials ETF
  218. Nine Energy Service
  219. Noco-Noco Inc
  220. Novartis
  221. Novavax
  222. Novo Nordisk
  223. NuScale Power Corp
  224. Ocean Biomedical Inc
  225. Omega Therapeutics
  226. OppFi
  227. Owlet
  228. Palantir Technologies
  229. Palo Alto Networks
  230. Panbela Therapeutics Inc
  231. Paramount Global
  232. PayPal
  233. Penn Entertainment
  234. PepGen Inc
  235. PepsiCo
  236. Perion Network
  237. Perrigo
  238. Pfizer
  239. Pinduoduo Inc - ADR
  240. Pinstripes Holdings Inc
  241. Pitney Bowes
  242. Pixelworks
  243. Privia Health Group
  244. ProShares UltraPro QQQ
  245. Progyny
  246. Quantasing Group Ltd
  247. QuantumScape
  248. R1 RCM Inc
  249. RLX Technology
  250. Rani Therapeutics Holdings
  251. Reddit Inc
  252. Regeneron Pharmaceuticals
  253. Repare Therapeutics
  254. Restaurant Brands
  255. Rigel Pharmaceuticals
  256. Riot Blockchain
  257. Rocket Lab USA
  258. Rocky Brands
  259. Roundhill Generative AI & Technology ETF
  260. SAGE Therapeutics
  261. SHF Holdings Inc
  262. Sanmina-SCI
  263. Sanofi
  264. Sarepta Therapeutics
  265. Scinai Immunotherapeutics Ltd
  266. Seelos Therapeutics
  267. Seres Therapeutics
  268. Serve Robotics Inc
  269. Shattuck Labs
  270. Shengfeng Development Ltd
  271. Shimmick Corp
  272. Shineco
  273. Skechers U.S.A.
  274. Sleep Number
  275. SoFi Technologies
  276. SolarEdge Technologies
  277. Solidion Technology Inc
  278. Sonoma Pharmaceuticals
  279. SoundHound AI Inc
  280. Sprott Uranium Miners ETF
  281. Spyre Therapeutics Inc
  282. Strive US Energy ETF
  283. Stronghold Digital Mining
  284. Stryker
  285. Summit Wireless Technologies Inc
  286. Super League Enterprise Inc
  287. Symbotic Inc
  288. TFF Pharmaceuticals
  289. Taiwan Semiconductor Manufacturing
  290. Telomir Pharmaceuticals Inc
  291. Tema Obesity & Cardiometabolic ETF
  292. Tesla
  293. Teva Pharmaceutical
  294. The Arena Group Holdings
  295. Theravance Biopharma
  296. Topgolf Callaway Brands Corp
  297. Travere Therapeutics
  298. Trump Media & Technology Group Corp
  299. Tupperware
  300. U-BX Technology Ltd
  301. Uber
  302. United Overseas Bank Ltd
  303. Unity Biotechnology Inc
  304. Upstart Holdings
  305. Upwork Inc
  306. Ur-Energy
  307. Uranium Royalty Corp
  308. Valley National
  309. Vanguard Information Technology ETF
  310. Vanguard S&P 500 ETF
  311. Vanguard Total Stock Market ETF
  312. Vast Solar Pty Ltd
  313. Verastem
  314. Verona Pharma
  315. Vertex Pharmaceuticals
  316. ViaSat
  317. Vicarious Surgical
  318. Vigil Neuroscience
  319. Viking Therapeutics
  320. Vintage Wine Estates
  321. Virco Mfg.
  322. Vivani Medical Inc
  323. Walgreens
  324. Walmart
  325. Wayfair
  326. Weightwatchers International Inc.
  327. Werewolf Therapeutics
  328. Xeris Biopharma Holdings
  329. Zimvie
  330. iShares PHLX Semiconductor ETF
  331. iShares Robotics & Artificial Intelligence Multisector ETF
  332. salesforce.com
  1. Asset
    Price
  2. 10X Genomics
  3. AP Moller - Maersk A/S
  4. ARK Industrial Innovation ETF
  5. ASML Hld
  6. Aceragen Inc
  7. Altria
6 Followers • 8 Following

Joni

@ucanttopmyramenHealthcare Education
Joni avatar

All of your investing.
All in one place.

Invest in stocks, treasuries, ETFs, crypto, and alternative assets on Public. Transfer your account to Public and get up to $10,000.
Sign Up
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2024 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Product offerings and availability vary based on jurisdiction.

Stocks, ETFs, Options, Bonds.
Self-directed brokerage accounts and brokerage services for US-listed, registered securities, options, and Bonds, except for treasury securities offered through Jiko Securities, Inc., are offered to self-directed customers by Open to the Public Investing, Inc. (“Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Public Investing is not registered. Securities products offered by Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Options.
Certain requirements must be met in order to trade options. Options can be risky and are not suitable for all investors. Options transactions are often complex, and investors can rapidly lose the entire amount of their investment or more in a short period of time. Investors should consider their investment objectives and risks carefully before investing in options. Refer to the Characteristics and Risks of Standardized Options before considering any options transaction. Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Options Order Flow Rebate.
If you are enrolled in our Options Order Flow Rebate Program, Public Investing will share 50% of our estimated order flow revenue for each completed options trade as a rebate to help reduce your trading costs. The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions.

Bonds.
“Bonds” shall refer to corporate debt securities and U.S. government securities offered on the Public platform through a self-directed brokerage account held at Public Investing and custodied at Apex Clearing. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. as explained under the “ Treasury Accounts” section.

Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa. Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Bond ratings, if provided, are third party opinions on the overall bond's credit worthiness at the time the rating is assigned. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes.

High-Yield Cash Account.
A High-Yield Cash Account is a secondary brokerage account with Public Investing. Funds in your High-Yield Cash Account are automatically deposited into partner banks (“Partner Banks”), where that cash earns interest and is eligible for FDIC insurance. See here for a list of current Partner Banks. Your Annual Percentage Yield is variable and may change at the discretion of the Partner Banks or Public Investing. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more.

Alternative Assets.
Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in a Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public Investing, and Public Investing (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency.
Cryptocurrency trading, execution, and custody services are provided by Bakkt Crypto Solutions, LLC (NMLS ID 1828849) (“Bakkt”). Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrencies offered by Bakkt are not securities and are not FDIC insured or protected by SIPC. Your cryptocurrency assets are held in your Bakkt account. Bakkt is a licensed virtual currency business by the New York State Department of Financial Services and a licensed money transmitter, but is not a registered broker-dealer or a FINRA member. Your Bakkt Crypto account is separate from your brokerage account with Public Investing, which holds US-listed stocks and ETFs. Please review the Risk Disclosures before trading.

Treasury Accounts.
Investing services in treasury accounts offering 6 month US Treasury Bills on the Public platform are through Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information.

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. Although T-bills are considered safer than many other financial instruments, you could lose all or a part of your investment. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading refers to $0 commissions charged on trades of US listed registered securities placed during the US Markets Regular Trading Hours in self-directed brokerage accounts offered by Public Investing. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Public’s Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

Investment Plans. US members only. Investment Plans (“Plans”) shown in our marketplace are for informational purposes only and are meant as helpful starting points as you discover, research and create a Plan that meets your specific investing needs. Plans are self-directed purchases of individually-selected assets, which may include stocks, ETFs and cryptocurrency. Plans are not recommendations of a Plan overall or its individual holdings or default allocations. Plans are created using defined, objective criteria based on generally accepted investment theory; they are not based on your needs or risk profile. You are responsible for establishing and maintaining allocations among assets within your Plan. Plans involve continuous investments, regardless of market conditions. Diversification does not eliminate risk. See our Investment Plans Terms and Conditions and Sponsored Content and Conflicts of Interest Disclosure.

Market Data. Quotes and other market data for Public’s product offerings are obtained from third party sources believed to be reliable, but Public makes no representation or warranty regarding the quality, accuracy, timeliness, and/or completeness of this information. Such information is time sensitive and subject to change based on market conditions and other factors. You assume full responsibility for any trading decisions you make based upon the market data provided, and Public is not liable for any loss caused directly or indirectly by your use of such information. Market data is provided solely for informational and/or educational purposes only. It is not intended as a recommendation and does not represent a solicitation or an offer to buy or sell any particular security.